References
- Craddock P. R., Fehr J., Brigham K. L., Kronenberg R. S., Jacob H. S. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. New Engl. J. Med. 1977; 296: 769–74
- Hammerschmidt D., Craddock P., McCullough J. Complement activation and pulmonary leukostasis during nylon fiber filtration leukapheresis. Blood 1978; 51: 721–30
- Chenoweth D. E., Hugli T. E. Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol. Immunol. 1980; 17: 151–61
- Craddock P. R., Hammerschmidt D., White J. G., Dalmasso A. P., Jacob H. S. Complement (C5a)-induced granulocyte aggregation in vitro: a possible mechanism of complement-mediated leukostasis and leukopenia. J. Clin. Invest. 1977; 60: 260–4
- Webster R. O., Hong S. R., Johnson R. B., Jr., Henson P. M. Biological effects of the human complement fragments C5a and C5a des Arg on neutrophil function. Immunopharmacology 1980; 2: 201–19
- O'Flaherty J. T., Kreutzer D. L., Ward P. A. Neutrophil aggregation and swelling induced by chemotactic agents. J. Immunol. 1977; 119: 232–9
- Skagseth E., Froysaker T., Refsom S. B. Disposable filter for microemboli in cardiopulmonary bypass. J. Cardiovasc. Surg. 1974; 15: 318–22
- Taylor K. M., Devlin B. J., Mittra S. M. Assessment of cerebral damage during open heart surgery - A new experimental model. Scand. J. Thorac. Cardiovasc. Surg. 1980; 14: 197–203
- Solis R. T., Noon G. P., Beall A. C. Particulate microembolism during cardiac operation. Ann. Thorac. Surg. 1974; 17: 332–44
- Reed C. C., Romagnoli A., Taylor D. E. Particulate matter in bubble oxygenators. J. Thorac. Cardiovasc. Surg. 1974; 68: 971–4
- Gallagher E. G., Pearson D. T. Ultrasonic identification of sources of gaseous microemboli during open-heart surgery. Thorax 1973; 28: 295–305
- Stoney W. S., Alford W. C., Burrus G. R., Glassford D. M., Thomas C. S. Air embolism and other accidents using pump oxygenators. Am. J. Thorac. Surg. 1980; 29: 336–48
- Cole J. G., Pauli W. A. Field Experiences in Testing Membrane Filter Integrity by the Forward Flow Test Method. Bul. Parent. Drug Assoc. 1975; 29: 296–304
- Hugli T. E., Chenoweth D. E. Biologically active peptides of complement: Techniques and significance of C3a and C5a measurements. Future Perspectives in Clinical Laboratory Immunoassays, R. M. Nekamura, W. R. Dito, E. S. Tucker, III. Alan R. Liss, New York 1980
- Platts-Mills T., Ishizaka K. Activation of the alternate pathway of human complement by rabbit cells. J. Immunol. 1974; 113: 348–58
- Remington R. D., Schork M. A. Statistics with Applications to Biological and Health Sciences. Prentice Hall, New Jersey 1970; 175–6
- Chenoweth D. E., Cooper B. A., Hugli T. E., Stewart R. W., Blackstone E. H., Kirklin J. W. Complement activation during cardiopulmonary bypass. New Engl. J. Med. 1981; 304: 497–503
- Herzlinger G., Cumming R. Complement-Biomaterial Interaction. Devices and Technology Branch-Contractors Meeting Proceedings. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health. November, 1980; 231–2, NIH Publication No. 81–2022
- Hammerschmidt D. E., Stroncek D. F., Bowers T. K. Complement activation and neutropenia occurring during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 1981; 81: 370–7
- Rent R., Ertel N., Eisenstein R., Gewurz H. Complement activation by interaction of polyanions and polycations. J. Immunol. 1975; 114: 120–4
- Caughman G. B., Boackle R. J., Vesely J. A postulated mechanism for heparin's potentiation of C1 inhibitor function. Mol. Immunol. 1982; 19: 287–95